Characterization of a Human Induced Pluripotent Stem Cell–Derived Cardiomyocyte Model for the Study of Variant Pathogenicity: Validation of a KCNJ2 Mutation

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Circulation: Cardiovascular Genetics

• Publication date

  2017-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCGENETICS.117.001755PMID 29021306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IK1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: an improved cardiomyocyte model to investigate inherited arrhythmia syndromes.

  2016cited by this paper
• Analysis of protein-coding genetic variation in 60,706 humans

  2015cited by this paper
• Andersen–Tawil syndrome: Report of 3 novel mutations and high risk of symptomatic cardiac involvement

  2015cited by this paper
• Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual IK1

  2015cited by this paper
• Electrocardiogram in Andersen-Tawil Syndrome. New Electrocardiographic Criteria for Diagnosis of Type-1 Andersen-Tawil Syndrome

  2014cited by this paper
• Andersen-Tawil syndrome: clinical and molecular aspects.

  2013cited by this paper
• Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics

  2013cited by this paper
• Comparative gene expression profiling in human-induced pluripotent stem cell--derived cardiocytes and human and cynomolgus heart tissue.

  2013cited by this paper
• The Disease-Specific Phenotype in Cardiomyocytes Derived from Induced Pluripotent Stem Cells of Two Long QT Syndrome Type 3 Patients

  2013cited by this paper
• Mechanism-Based Facilitated Maturation of Human Pluripotent Stem Cell–Derived Cardiomyocytes

  2013cited by this paper
• Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing.

  2013cited by this paper
• Disease characterization using LQTS-specific induced pluripotent stem cells

  2013cited by this paper
• Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells.

  2013cited by this paper
• Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype.

  2013cited by this paper
• Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing.

  2012cited by this paper
• Dynamic reciprocity of sodium and potassium channel expression in a macromolecular complex controls cardiac excitability and arrhythmia

  2012cited by this paper
• Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias

  2012cited by this paper
• Phenotype Variability in Patients Carrying KCNJ2 Mutations

  2012cited by this paper
• Cardiomyocytes Derived From Pluripotent Stem Cells Recapitulate Electrophysiological Characteristics of an Overlap Syndrome of Cardiac Sodium Channel Disease

  2012cited by this paper
• Disease characterization using LQTS-specific induced pluripotent stem cells.

  2012cited by this paper
• Modelling the long QT syndrome with induced pluripotent stem cells

  2011cited by this paper
• High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.

  2011cited by this paper
• Using iPS cells to investigate cardiac phenotypes in patients with Timothy Syndrome

  2011cited by this paper
• Cardiomyocytes Obtained From Induced Pluripotent Stem Cells With Long-QT Syndrome 3 Recapitulate Typical Disease-Specific Features In Vitro

  2011cited by this paper
• Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture

  2011cited by this paper
• Kir 2.1 channelopathies: the Andersen–Tawil syndrome

  2010cited by this paper
• Patient-specific induced pluripotent stem-cell models for long-QT syndrome.

  2010cited by this paper
• Mechanisms of Disease: ion channel remodeling in the failing ventricle

  2008cited by this paper
• Effect of clinical phenotype on yield of long QT syndrome genetic testing.

  2005cited by this paper
• Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing.

  2004cited by this paper
• Surface Expression of Inward Rectifier Potassium Channels Is Controlled by Selective Golgi Export*

  2003cited by this paper
• Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome.

  2003cited by this paper
• Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression.

  2003cited by this paper
• The consequences of disrupting cardiac inwardly rectifying K+ current (IK1) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes

  2001cited by this paper
• Inward rectifiers in the heart: an update on I(K1).

  2001cited by this paper
• Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle.

  1998cited by this paper
• Differential effects of chronic membrane depolarization on the K+ channel activities in cultured rat ventricular cells.

  1997cited by this paper
• Diagnostic Criteria for the Long QT Syndrome An Update

  1993cited by this paper

• Development of a high-speed imaging system for real time evaluation and monitoring of cardiac engineered tissues

  2024cites this paper
• A highly versatile biopolymer-based platform for the maturation of human pluripotent stem cell-derived cardiomyocytes enables functional analysis in vitro and 3D printing of heart patches.

  2023cites this paper
• Micro-2D Cell Culture for cAMP Measurements Using FRET Reporters in Human iPSC-Derived Cardiomyocytes.

  2022cites this paper
• Investigation of the Effects of the Short QT Syndrome D172N Kir2.1 Mutation on Ventricular Action Potential Profile Using Dynamic Clamp

  2022cites this paper
• Inwardly Rectifying Potassium Channel Kir2.1 and its “Kir-ious” Regulation by Protein Trafficking and Roles in Development and Disease

  2022cites this paper
• Patient-specific induced pluripotent stem cells as “disease-in-a-dish” models for inherited cardiomyopathies and channelopathies – 15 years of research

  2021cites this paper
• Application of the Pluripotent Stem Cells and Genomics in Cardiovascular Research—What We Have Learnt and Not Learnt until Now

  2021cites this paper
• The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases

  2020cites this paper
• Inherited cardiac diseases, pluripotent stem cells, and genome editing combined—the past, present, and future

  2019cites this paper
• Induced Pluripotent Stem Cells in Disease Modelling and Regeneration.

  2019cites this paper
• Medical Applications of iPS Cells

  2019influential citation
• Modeling Cardiomyopathies with iPSCs

  2019cites this paper
• Comparative effects of parent and heated cinnamaldehyde on the function of human iPSC-derived cardiac myocytes.

  2019cites this paper
• Cardiac Repolarization and Stem Cells: An Emerging Path Toward Precision Medicine

  2019cites this paper
• Disease Associated Mutations in KIR Proteins Linked to Aberrant Inward Rectifier Channel Trafficking

  2019cites this paper
• Genetic Testing for Inherited Cardiac Arrhythmias: Current State-of-the-Art and Future Avenues

  2018cites this paper
• Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists

  2018cites this paper
• Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant.

  2018cites this paper
• Human-Induced Pluripotent Stem Cell – Derived Cardiomyocytes Another Piece in Our Tool Box , but Not a Swiss Army Knife Yet

  2017cites this paper